National Accreditation Program for Rectal Cancer

The National Accreditation Program for Rectal Cancer (NAPRC) was formed to address the differences between patient outcomes in the United States as compared to Europe.[1][2] According to the American College of Surgeons, outcomes for rectal cancer patients in Europe have for years been significantly better than for those in the U.S. Characterized by the use of multidisciplinary teams to make treatment decisions, the NAPRC standards aim to decrease the average circumferential resection margins, decrease the overall colostomy rate, and increase quality of life as reported by recovering patients.[3][4][5] [6]

National Accreditation Program for Rectal Cancer

Two statistics illustrate the difference in treatment. A decade ago, the colostomy rate in Europe ranged from 25 percent to 35 percent, while today’s colostomy rate in the U.S. is about 50 percent, meaning that many more patients in the U.S. have colostomies as compared to Europeans. Rectal cancer cases in the U.S. have an average circumferential resection margins (CRMs) rate of 17 percent, significantly higher than the 3 percent to 11 percent range for European countries.[7]

Background

edit

Collaboration between numerous professional organizations served as the driving force behind the creation of the NAPRC and its standards.[8] To create the new standards and address the disparities between treatment in Europe and the U.S., the OSTRiCh (Optimizing Surgical Treatment of Rectal Cancer) Consortium was created by the American College of Surgeons and its Commission on Cancer (CoC) working with the American Society of Colon and Rectal Surgeons (ASCRS), the College of American Pathologists, the American College of Radiology, the Society of Gastrointestinal and Endoscopic Surgeons (SAGES), the Society for the Surgery of the Alimentary Tract and Society of Surgical Oncology. Lead members of the steering committee include Steven D. Wexner, MD, FACS, past president of the ASCRS, and Frederick L. Greene, MD, FACS, past chair of the CoC. The NAPRC is the fourth accreditation program approved by the CoC.

Prior to the CoC's creation of the NAPRC, a study was conducted on the current state of treatment in the US. The study was published in the Journal of the American College of Surgeons. The results showed that the full set of proposed quality standards were only met in 28.1% of patients, who were all diagnosed between 2011 and 2014 with non-metastatic rectal cancer.[9] The completion of these measures varied based on location of the facility, type of facility, insurance, race, stage of disease, and operative volume.[10] </ref> The study's authors plan to review the data once more in two or three years,[11] According to the CoC, an inclusive approach was taken with the goal of providing the maximum number of patients with the option to go to an accredited facility.

In June 2017 the ACS issued a press release stating that the NAPRC is accepting applications.[12] Accreditation requires previous CoC accreditation, an on-site visit, and records showing that NAPRC standards have been in place for no less than twelve months.

The chair of the NAPRC is Steven D. Wexner, MD. The vice chair is James W. Fleshman, Jr., MD.

Standards

edit

One of the main requirements of maintaining NAPRC accreditation is having multidisciplinary teams, i.e., the establishment and use of teams that include not only the surgeon, but also representatives from pathology, radiology, imaging, and medical oncology.[13] This is similar to the existing National Accreditation Program for Breast Cancer, which various facilities already have in place.[14] This team model is based on European standards of care and medical practice,[15] and it entails collaboration by team members on decisions regarding therapy and all aspects of surgical treatment. When these multidisciplinary teams were put into place in Europe, they saw improved outcomes for patients as well as a decrease in recurrence rates and an increase in overall survival rates.[16]

Another main requirement is the use of synoptic rather than narrative reporting. According to the American College of Surgeons, synoptic reports have been shown to collect 99 percent of critical patient data, while narrative reports typically capture less than 50 percent, according to studies on the subject. When patients are provided with specific checklists and questions, they report significantly more details which may be pertinent to future care.

Overall there are 22 different standards in the accreditation program, which each fall into one of three categories: program management, clinical services, or quality improvement.[17] [18] These were tested at six hospitals prior to being finalized.[19]

Standard Number Standard
Chapter 1 Program Management
1.1 Commission on Cancer Accreditation
1.2 Rectal Cancer Multidisciplinary Care
1.3 Rectal Cancer Multidisciplinary Team Attendance
1.4 Rectal Cancer Multidisciplinary Team Meetings
1.5 Rectal Cancer Program Director
1.6 Rectal Cancer Program Coordinator
1.7 Rectal Cancer Program Education
Chapter 2 Clinical Services
2.1 Review of Diagnostic Pathology
2.2 Staging before Definitive Treatment
2.3 Standardized Staging Reporting for Magnetic Resonance Imaging Results
2.4 Carcinoembryonic Antigen Level
2.5 Rectal Cancer Multidisciplinary Team Treatment Planning Discussion
2.6 Treatment Evaluation and Recommendation Summary
2.7 Definitive Treatment Timing
2.8 Surgical Resection and Standardized Operative Reporting
2.9 Pathology Reports after Surgical Resection
2.10 Photographs of Surgical Specimens
2.11 Multidisciplinary Team Treatment Outcome Discussion
2.12 Treatment Outcome Discussion Summary
2.13 Adjuvant Therapy after Surgical Resection
Chapter 3 Quality Improvement
3.1 Rapid Quality Reporting System
3.2 Accountability and Quality Improvement Measures

Accredited programs

edit

The NAPRC began accepting applications in July 2017.[20]

As of June 2018, the following institutions have completed the full survey process to receive accreditation:

John Muir Health Rectal Program in Walnut Creek and Concord, CA

Cleveland Clinic Weston Rectal Cancer Program in Weston, FL[21]

References

edit
  1. ^ Wexner, Steven D.; Berho, Mariana E. (2017). "The Rationale for and Reality of the New National Accreditation Program for Rectal Cancer". Diseases of the Colon and Rectum. 60 (6): 595–602. doi:10.1097/DCR.0000000000000840. ISSN 1530-0358. PMID 28481853. S2CID 25720496.
  2. ^ Orangio, Guy R. (2018). "A National Accreditation Program for Rectal Cancer: A Long and Winding Road". Diseases of the Colon & Rectum. 61 (2): 145–146. doi:10.1097/DCR.0000000000001011. ISSN 0012-3706. PMID 29337764. S2CID 13573153.
  3. ^ "Improving rectal cancer outcomes through advocacy, education, and research: The OSTRiCh Consortium and the new NAPRC | The Bulletin". The Bulletin. 2016-11-01. Retrieved 2018-01-03.
  4. ^ Wexner, Steven D; Berho, Mariana E (2017). "The Rationale for and Reality of the New National Accreditation Program for Rectal Cancer". Diseases of the Colon & Rectum. 60 (6): 595–602. doi:10.1097/DCR.0000000000000840. PMID 28481853. S2CID 25720496.
  5. ^ "New National Accreditation Program for Rectal Cancer 2017". Cleveland Clinic Center for Continuing Education. Cleveland Clinic Foundation Center for Continuing Education and Cleveland Clinic Simulation and Advanced Skills Center.
  6. ^ "New accreditation program sets framework for rectal cancer care in the US". EurekaAert!. AMERICAN COLLEGE OF SURGEONS.
  7. ^ "New rectal cancer accreditation program chases Europe's success". American College of Surgeons. Retrieved 2018-01-03.
  8. ^ "Initiative Promotes Multidisciplinary Approach To Improve Rectal Cancer Outcomes". Retrieved 2018-01-03.
  9. ^ Brady, Justin T; Xu, Zhaomin; Scarberry, Kelly B; Saad, Amin; Fleming, Fergal J; Remzi, Feza H; Wexner, Steven D; Winchester, David P; Monson, John R.T; Lee, Lawrence; Dietz, David W (2018). "Evaluating the Current Status of Rectal Cancer Care in the US: Where We Stand at the Start of the Commission on Cancer's National Accreditation Program for Rectal Cancer". Journal of the American College of Surgeons. 226 (5): 881–890. doi:10.1016/j.jamcollsurg.2018.01.057. PMID 29580675.
  10. ^ "New Accreditation Program Sets Framework For Rectal Cancer Care In The US". MDT. by American College of Surgeons. Retrieved 16 July 2018.
  11. ^ "New Accreditation Program Sets Framework For Rectal Cancer Care In The US". Bioengineer. Bioengineer.Org. Retrieved 16 July 2018.
  12. ^ "National Accreditation Program for Rectal Cancer Is Now Accepting Applications". American College of Surgeons. Retrieved 2018-01-03.
  13. ^ Berho, Mariana; Narang, Rahul; Van Koughnett, Julie Ann M; Wexner, Steven D (2015). "Modern Multidisciplinary Perioperative Management of Rectal Cancer". JAMA Surgery. 150 (3): 260–6. doi:10.1001/jamasurg.2014.2887. PMID 25629513.
  14. ^ "National Accreditation Program For Rectal Cancer (NAPRC) Unveiled". Chartis Oncology Solutions. Chartis Oncology Solutions. Retrieved 16 July 2018.
  15. ^ Wexner, Steven (17 April 2018). "The National Accreditation Program for Rectal Cancer | ACPGBI". ACPGBI. ACPGBI. Retrieved 16 July 2018.
  16. ^ "New accreditation program for rectal cancer emphasizes multidisciplinary approach - ACS Clinical Congress News". ACSCC News. ACSCC News. Retrieved 16 July 2018.
  17. ^ "National Accreditation Program For Rectal Cancer (NAPRC) Unveiled". Chartis Oncology Solutions. Chartis Oncology Solutions. Retrieved 16 July 2018.
  18. ^ "The National Accreditation Program for Rectal Cancer Standards Manual 2017 edition (revised october 2017)". American College of Surgeons. The National Accreditation Program for Rectal Cancer. Retrieved 16 July 2018.
  19. ^ "Initiative Promotes Multidisciplinary Approach To Improve Rectal Cancer Outcomes". General Surgery News. General Surgery News. Retrieved 16 July 2018.
  20. ^ "NAPRC Now Accepting Applications from Hospitals teaser". MDEdge. MDEdge. Retrieved 16 July 2018.
  21. ^ "Accredited Rectal Cancer Programs". American College of Surgeons. American College of Surgeons. Retrieved 16 July 2018.